Ginkgo Bioworks Holdings (DNA) Research & Development (2020 - 2026)

Ginkgo Bioworks Holdings' Research & Development history runs 7 years deep, the most recent figure standing at $49.9 million for Q1 2026.

• Quarterly Research & Development fell 29.61% year-over-year to $49.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $222.8 million (down 37.87% YoY) and the FY2025 annual result came in at $243.8 million, down 42.51% from the prior year.
• Research & Development was $49.9 million for Q1 2026 at Ginkgo Bioworks Holdings, roughly flat from $50.1 million in the prior quarter.
• Across five years, Research & Development topped out at $323.6 million in Q1 2022 and bottomed at $49.9 million in Q1 2026.
• A 5-year average of $138.3 million and a median of $134.2 million in 2024 frame the typical range for Research & Development.
• Peak annual rise in Research & Development reached 457.47% in 2022, while the deepest fall reached 81.98% in 2022.
• Ginkgo Bioworks Holdings' Research & Development stood at $177.5 million in 2022, then slumped by 34.08% to $117.0 million in 2023, then plunged by 34.74% to $76.4 million in 2024, then sank by 34.37% to $50.1 million in 2025, then fell by 0.41% to $49.9 million in 2026.
• Business Quant data shows DNA's Research & Development at $49.9 million in Q1 2026, $50.1 million in Q4 2025, and $69.4 million in Q3 2025.